NASDAQ:ATRC
AtriCure Stock News
$20.89
-1.33 (-5.99%)
At Close: May 03, 2024
AtriCure to Announce Second Quarter 2020 Financial Results
12:00pm, Tuesday, 07'th Jul 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its second quarter 2020
Xenon Lights Market Trajectory & Analytics to 2027 - COVID-19 Updated - ResearchAndMarkets.com
12:00am, Tuesday, 07'th Jul 2020
The
Is Apple about to buy smart speaker giant Sonos?
08:46am, Tuesday, 23'rd Jun 2020
A Sonos-Apple allegiance could be on the cards
Hedge Funds Are Buying AtriCure Inc. (ATRC)
04:45pm, Friday, 19'th Jun 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 18)
ADC Therapeutics SA (NYSE:...
Edited Transcript of ATRC earnings conference call or presentation 29-Apr-20 8:30pm GMT
05:43pm, Monday, 18'th May 2020
Q1 2020 AtriCure Inc Earnings Call
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Protalix Fabry Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
06:09pm, Tuesday, 12'th May 2020
Protalix reported positive data from its Fabry disease trial. AtriCure reported positive data from its CONVERGE Study. Oyster Point Pharma reported mixed toplin
Edited Transcript of ATRC earnings conference call or presentation 29-Apr-20 8:30pm GMT
07:49am, Tuesday, 12'th May 2020
Q1 2020 AtriCure Inc Earnings Call
